Act1 Adaptor Protein Is an Immediate and Essential Signaling Component of Interleukin-17 Receptor
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-17, the founding member of the IL-17 cytokine family, is the hallmark of a novel subset of CD4+ T cells that is regulated by TGFbeta, IL-6, and IL-23. IL-17 plays an important role in promoting tissue inflammation in host defense against infection and in autoimmune diseases. Although IL-17 has been reported to regulate the expression of proinflammatory cytokines, chemokines, and matrix metalloproteinases, the signaling mechanism of IL-17 receptor has not been understood. An earlier study found that IL-17 activates NF-kappaB and MAPK pathways and requires TRAF6 to induce IL-6. However, it is unknown what molecule(s) directly associates with IL-17 receptor to initiate the signaling. We demonstrate here that IL-17 receptor family shares sequence homology in their intracellular region with Toll-IL-1 receptor (TIR) domains and with Act1, a novel adaptor previously reported as an NF-kappaB activator. MyD88 and IRAK4, downstream signaling components of TIR, are not required for IL-17 signaling. On the other hand, Act1 and IL-17 receptor directly associate likely via homotypic interaction. Deficiency of Act1 in fibroblast abrogates IL-17-induced cytokine and chemokine expression, as well as the induction of C/EBPbeta, C/EBPdelta, and IkappaBzeta. Also, absence of Act1 results in a selective defect in IL-17-induced activation of NF-kappaB pathway. These results thus indicate Act1 as a membrane-proximal adaptor of IL-17 receptor with an essential role in induction of inflammatory genes. Our study not only for the first time reveals an immediate signaling mechanism downstream of an IL-17 family receptor but also has implications in therapeutic treatment of various immune diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Act1 is best understood as a nonredundant activator of IL-17RA-dependent signals”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chang et al., 2006
In the citing paper
“TRAF6 also promotes activation of MAPK/AP1 pathways and the C/EBPβ and δ transcription factors”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chang et al., 2006
Citations
Cites
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Self-citationKawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810
Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties
Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., & Murphy, K. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.002 · Cited by 1,422
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., & Peschon, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.36 · Cited by 570
Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells
Dong, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1807 · Cited by 487
Self-citationKao, C.-Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R. W., & Wu, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3482 · Cited by 424
Shalom-Barak, T., Quach, J., & Lotz, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27467 · Cited by 388
Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364
Schwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349
Cited by
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
“The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.”
BackgroundThe Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700
“Indeed , Act1 binds to the cytoplasmic domain of IL-17RA (Chang et al., 2006b) and is a functional adaptor critical for IL-17RA signaling and the development of EAE and dextran-sodium-sulfateinduced colitis (Qian et al., 2007).”
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“TRAF6 also promotes activation of MAPK/AP1 pathways and the C/EBPβ and δ transcription factors (Chang et al., 2006; Maitra et al., 2007; Qian et al., 2007; Ruddy et al., 2004).”
BackgroundTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
TH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064
“Recently, the adaptor protein ACT1 has been identified as an immediate and essential signalling component of IL-17R”
BackgroundSelf-citationInterleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800
“Real-Time PCR The expression of Ccl20, Ccl2, Ccl7, Ccr6, and Gro-a was performed with specific primers reported previously (Chang and Dong, 2007; Chang et al., 2006) and the BioRad SYBRgreen system.”
MethodSelf-citationInterleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Evidence for a cross-talk between human neutrophils and Th17 cells
Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., Cosmi, L., Lunardi, C., Annunziato, F., Romagnani, S., et al. (2010) · Blood · doi:10.1182/blood-2009-04-216085 · Cited by 782
“This, in turn, recruits a cytoplasmic adaptor protein, Act1, which is essential for intracellular signal transduction.(4)”
BackgroundIL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“Act1 contains a SEFIR domain and interacts with IL-17RA and IL-17RC through homotypic SEFIR interactions [31, 33].”
BackgroundRegulation of inflammatory responses by IL-17F
Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H., Schluns, K. S., Broaddus, R. R., Zhu, Z., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071978 · Cited by 739
Self-citationIL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595
“Act1-deficiency results in a loss of IL-17dependent NFκB activation and pro-inflammatory cytokine production [46, 47].”
BackgroundCytokine Regulation and Function in T Cells
Dong, C. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-061020-053702 · Cited by 588
Self-citationCCR6 Regulates the Migration of Inflammatory and Regulatory T Cells
Yamazaki, T., Yang, X. O., Chung, Y., Fukunaga, A., Nurieva, R., Pappu, B., Martin-Orozco, N., Kang, H. S., Ma, L., Panopoulos, A. D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8391 · Cited by 551
Self-citationIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
IL-17 cytokines in immunity and inflammation
Jin, W., & Dong, C. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.58 · Cited by 529
Self-citationThe roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513
The Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 475
“Upon ligand binding, this molecule is engaged to the IL-17R complex through homotypic SEFIR interactions to mediate downstream events (53).”
BackgroundThe IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
“IL-17A signaling begins when IL-17R specifically binds to the SEFIR isotype present in Act1 through its intracellular SEFIR domain.(33,34) Act1 is also functionally associated to the connection to IκB kinase and stress-activated protein kinases (CIKS).”
BackgroundTRAF molecules in cell signaling and in human diseases
Xie, P. (2013) · Journal of Molecular Signaling · doi:10.1186/1750-2187-8-7 · Cited by 466
“Activated NF-κB further induces the expression of IkBζ, C/EBPδ and C/EBPβ, transcription factors that work in concert with NF-κB to induce the expression of signature target genes of IL-17 [12,147,154-158].”
BackgroundOligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair
Domingues, H. S., Portugal, C. C., Socodato, R., & Relvas, J. B. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00071 · Cited by 432
Th17 cells: Effector T cells with inflammatory properties
Korn, T., Oukka, M., Kuchroo, V., & Bettelli, E. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.007 · Cited by 445
“The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.”
BackgroundZhu, S., Pan, W., Song, X., Liu, Y., Shao, X., Tang, Y., Liang, D., He, D., Wang, H., Liu, W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2815 · Cited by 396
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
Liu, T., Li, S., Ying, S., Tang, S., Ding, Y., Li, Y., Qiao, J., & Fang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594735 · Cited by 386
An overview of IL-17 function and signaling
Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.017 · Cited by 382
Interleukin-17 and its expanding biological functions
Xu, S., & Cao, X. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.21 · Cited by 357
Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F
Kuestner, R. E., Taft, D. W., Haran, A., Brandt, C. S., Brender, T., Lum, K., Harder, B., Okada, S., Ostrander, C. D., Kreindler, J. L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5462 · Cited by 352
Somatic inflammatory gene mutations in human ulcerative colitis epithelium
Nanki, K., Fujii, M., Shimokawa, M., Matano, M., Nishikori, S., Date, S., Takano, A., Toshimitsu, K., Ohta, Y., Takahashi, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1844-5 · Cited by 325
Rickel, E. A., Siegel, L. A., Yoon, B.-R. P., Rottman, J. B., Kugler, D. G., Swart, D. A., Anders, P. M., Tocker, J. E., Comeau, M. R., & Budelsky, A. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4299 · Cited by 321
“For example, IL-17RA does not contain a TRAF6-binding motif but it has been reported to recruit TRAF6 by directly associating with the adaptor protein Act1 which does contain a TRAF6-binding motif (29).”
BackgroundEffect of IL-17A blockade with secukinumab in autoimmune diseases
Patel, D. D., Lee, D. M., Kolbinger, F., & Antoni, C. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202371 · Cited by 313
“IL-17RA and IL-17RC are members of a newly discovered family of cytokine receptors (figure 1) that mediate signalling through a distinct pathway that depends on Act1 (also known as CIKS (Connection to IKK and SAPK/JNK)), resulting in the activation of proinflammatory mediators typically associated with the innate immu…”
BackgroundSong, X., Zhu, S., Shi, P., Liu, Y., Shi, Y., Levin, S. D., & Qian, Y. (2011) · Nature Immunology · doi:10.1038/ni.2155 · Cited by 312
Boisson, B., Wang, C., Pedergnana, V., Wu, L., Cypowyj, S., Rybojad, M., Belkadi, A., Picard, C., Abel, L., Fieschi, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.002 · Cited by 293
“The ACT1mutation was chosen for further investigation as a potential disease-causing gene due to its potential impact on IL-17 pathways (Chang et al., 2006; Chang et al., 2011; Qian et al., 2007).”
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
Huang, H., Kim, H. J., Chang, E.-J., Lee, Z. H., Hwang, S. J., Kim, H.-M., Lee, Y., & Kim, H.-H. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.74 · Cited by 272
“Furthermore, Act1 was recently shown to associate with both TRAF6 and the IL-17 receptor in fibroblasts.(23) To examine the roles of TRAF6 and Act1 in IL-17-dependent signaling, we first examined the expression of these two proteins in”
BackgroundRecent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses
Chang, S. H., & Dong, C. (2007) · Cell Research · doi:10.1038/cr.2007.35 · Cited by 280
Self-citationIL-17 Enhances Chemokine Gene Expression through mRNA Stabilization
Hartupee, J., Liu, C., Novotny, M., Li, X., & Hamilton, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4135 · Cited by 282
“The cytoplasmic adaptor protein Act1 has recently been shown to interact with the IL-17R and to be required for IL-17-induced proinflammatory gene expression (26, 39).”
BackgroundInterleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
Chang, S. H., Reynolds, J. M., Pappu, B. P., Chen, G., Martinez, G. J., & Dong, C. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.010 · Cited by 271
“IL-17RA recruits a membrane proximal adaptor protein, Act1, to mediate IL-17A, IL-17F, and IL-25 signaling (Chang et al., 2006; Claudio et al., 2009; Qian et al., 2007).”
Self-citationTh17 cytokines and mucosal immunity
Dubin, P. J., & Kolls, J. K. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00703.x · Cited by 244
“While IL-17RA binds to IL-17A with a relatively weak affinity (17), binding of IL-17F is considerably weaker, with initial reports demonstrating no evidence of IL-17F binding by surface plasmon resonance to IL-17RA (18).”
BackgroundInfluentialShen, F., & Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.013 · Cited by 256
“This event is followed by recruitment of TAK1/TRAF6, degradation of IjBa, and IL-17-dependent activation of NF-jB [131,149].”
BackgroundInfluentialThe role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
“Act1 is the key adaptor molecule directly recruited to IL17R and is required for both the transcriptional and posttranscriptional changes induced by IL-17 (Chang et al., 2006; Herjan et al., 2018; Qian et al., 2007).”
BackgroundGrowth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage
Song, X., Dai, D., He, X., Zhu, S., Yao, Y., Gao, H., Wang, J., Qu, F., Qiu, J., Wang, H., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.024 · Cited by 243
IL-17 family member cytokines: Regulation and function in innate immunity
Reynolds, J. M., Angkasekwinai, P., & Dong, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.002 · Cited by 235
“The cytokines IL-17 and IL-17F employ the adaptors TRAF6 and Act1 in their signaling transduction pathways as well(27,28).”
BackgroundSelf-citationSignaling of interleukin-17 family cytokines in immunity and inflammation
Chang, S. H., & Dong, C. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.022 · Cited by 229
Self-citationRegulation of IL-9 expression by IL-25 signaling
Angkasekwinai, P., Chang, S. H., Thapa, M., Watarai, H., & Dong, C. (2010) · Nature Immunology · doi:10.1038/ni.1846 · Cited by 228
“We showed that IL-17RA binds to Act1 adaptor protein through the SEFIR (similar expression to fibroblast growth factor genes and IL-17Rs) domain 17.”
Self-citationSun, D., Novotny, M., Bulek, K., Liu, C., Li, X., & Hamilton, T. (2011) · Nature Immunology · doi:10.1038/ni.2081 · Cited by 232
IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224
Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling · doi:10.1126/scisignal.2000382 · Cited by 224
“Act1 is an essential component in IL-17 signaling and is required for IL-17– dependent immune responses (7, 8).”
BackgroundWu, L., Chen, X., Zhao, J., Martin, B., Zepp, J. A., Ko, J. S., Gu, C., Cai, G., Ouyang, W., Sen, G., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150204 · Cited by 221
“IL-17A–dependent ERK5 activation was indeed dependent on MEKK3, whereas the activation of NF-B, p38, and ERK1/2 were not (Fig.”
BackgroundInfluentialHuang, F., Kao, C.-Y., Wachi, S., Thai, P., Ryu, J., & Wu, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6504 · Cited by 209
“The fact that the SEFIR domain belongs to the STIR superfamily (SEFIR and (TIR)) (28, 29) suggests a connection between TIR-signaling molecules such as TNFR-associated factor 6 (TRAF6) and TGF- -activated kinase 1 (TAK1) and IL17AR signal pathways.”
BackgroundZhong, B., Liu, X., Wang, X., Chang, S. H., Liu, X., Wang, A., Reynolds, J. M., & Dong, C. (2012) · Nature Immunology · doi:10.1038/ni.2427 · Cited by 206
Self-citationThe activation and regulation of IL-17 receptor mediated signaling
Song, X., & Qian, Y. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.014 · Cited by 206
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
Hot, A., & Miossec, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143768 · Cited by 201
Xiang, T., Long, H., He, L., Han, X., Lin, K., Liang, Z., Zhuo, W., Xie, R., & Zhu, B. (2015) · Oncogene · doi:10.1038/onc.2013.537 · Cited by 194
Cheung, P. F. Y., Wong, C. K., & Lam, C. W. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5625 · Cited by 200
“IL-17A and IL-17F are members of the IL-17 family that play crucial roles in allergic inflammation.”
BackgroundInfluentialEnhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
Tsoi, L. C., Spain, S. L., Ellinghaus, E., Stuart, P. E., Capon, F., Knight, J., Tejasvi, T., Kang, H. M., Allen, M. H., Lambert, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8001 · Cited by 195
Structural basis of receptor sharing by interleukin 17 cytokines
Ely, L. K., Fischer, S., & Garcia, K. C. (2009) · Nature Immunology · doi:10.1038/ni.1813 · Cited by 195
“However, IL-17 receptor signaling does not use the same set of membrane-proximal adaptor molecules as Toll-like receptor signaling does; IL-17R requires the adaptor Act1, which also contains a SEF–IL-17R domai”
BackgroundInterleukin-17 enhances immunosuppression by mesenchymal stem cells
Han, X., Yang, Q., Lin, L., Xu, C., Zheng, C., Chen, X., Han, Y., Li, M., Cao, W., Cao, K., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.85 · Cited by 189
“Upon IL-17 binding, IL-17RA recruits Act1, a critical downstream mediator of the IL-17-induced signaling process.(9,10) Although much is known about the IL-17-induced signaling pathways, its cellular targets and mode of action during inflammatory processes and autoimmune diseases”
BackgroundBulek, K., Liu, C., Swaidani, S., Wang, L., Page, R. C., Gulen, M. F., Herjan, T., Abbadi, A., Qian, W., Sun, D., et al. (2011) · Nature Immunology · doi:10.1038/ni.2080 · Cited by 192
The IL-23/IL-17 axis in psoriatic arthritis
Suzuki, E., Mellins, E. D., Gershwin, M. E., Nestle, F. O., & Adamopoulos, I. E. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.050 · Cited by 186
“Another susceptibility locus identified by GWAS is tumor necrosis factor receptor-associated factor 3-interacting protein interacting protein 2 (TRAF3IP2), which encodes Act1 [74].”
BackgroundInterleukin-17: A novel inflammatory cytokine that bridges innate and adaptive immunity
Yu, J. (2008) · Frontiers in Bioscience · doi:10.2741/2667 · Cited by 178
“Signaling through IL-17RA however, parallels the signaling observed in innate cytokine receptors such as IL-1R and TLRs and converges to similar endpoints, such as activation of MAPK, NF-kappaB and C/EBP.”
BackgroundInfluentialIL-17F: Regulation, signaling and function in inflammation
Chang, S. H., & Dong, C. (2009) · Cytokine · doi:10.1016/j.cyto.2008.12.024 · Cited by 169
Self-citationIL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms
Ha, H.-L., Wang, H., Pisitkun, P., Kim, J.-C., Tassi, I., Tang, W., Morasso, M. I., Udey, M. C., & Siebenlist, U. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400513111 · Cited by 171
“heterotypic SEFIR domain association (22, 23).”
Lévy, R., Okada, S., Béziat, V., Moriya, K., Liu, C., Chai, L. Y. A., Migaud, M., Hauck, F., Al Ali, A., Cyrus, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618300114 · Cited by 174
Th17 Cytokines Regulate Osteoclastogenesis in Rheumatoid Arthritis
Kim, K.-W., Kim, H.-R., Kim, B.-M., Cho, M.-L., & Lee, S.-H. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.07.017 · Cited by 162
Maitra, A., Shen, F., Hanel, W., Mossman, K., Tocker, J., Swart, D., & Gaffen, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611589104 · Cited by 165
IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases
Song, X., & Qian, Y. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.021 · Cited by 162
IL-25 (IL-17E) in epithelial immunology and pathophysiology
Borowczyk, J., Shutova, M., Brembilla, N. C., & Boehncke, W.-H. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.12.628 · Cited by 158
Targeting the tumor microenvironment: the protumor effects of IL-17 related to cancer type
Fabre, J., Giustiniani, J., Garbar, C., Antonicelli, F., Merrouche, Y., Bensussan, A., Bagot, M., & Al-Dacak, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091433 · Cited by 159
“To comfort this, Act1 knockdown experiences showed abrogation of IL-17 induced inflammatory gene expression and NF-κB activation [42].”
BackgroundHu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 174
Cho, K., Suh, J. W., Lee, K. H., Kang, J. L., & Woo, S. (2011) · International Immunology · doi:10.1093/intimm/dxr110 · Cited by 161
IL-17 and the Th17 lineage in systemic lupus erythematosus
Garrett-Sinha, L. A., John, S., & Gaffen, S. L. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328304b6b5 · Cited by 150
IL-17-induced NF-κB Activation via CIKS/Act1
Sønder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F., & Siebenlist, U. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199547 · Cited by 146
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Th17 cells and IL-17 A—Focus on immunopathogenesis and immunotherapeutics
van den Berg, W. B., & McInnes, I. B. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.04.006 · Cited by 154
The Adaptor Protein CIKS/Act1 Is Essential for IL-25-Mediated Allergic Airway Inflammation
Claudio, E., Sønder, S. U., Saret, S., Carvalho, G., Ramalingam, T. R., Wynn, T. A., Chariot, A., Garcia-Perganeda, A., Leonardi, A., Paun, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1617 · Cited by 141
“In agreement with prior studies (19, 20), IL-17 was able to induce target genes such as IL-6 and GM-CSF alone and/or in synergy with TNF- in WT MEFs, but not in CIKSdeficient MEFs; this was demonstrated by real-time PCR analysis (Fig.”
BackgroundZhu, S., Pan, W., Shi, P., Gao, H., Zhao, F., Song, X., Liu, Y., Zhao, L., Li, X., Shi, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100703 · Cited by 138
“We and others discovered that Act1 is required for IL-17–mediated signaling and induction of downstream genes (Chang et al., 2006; Qian et al., 2007).”
Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
Bugaut, H., & Aractingi, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621956 · Cited by 151
Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation
Reynolds, J. M., Lee, Y.-H., Shi, Y., Wang, X., Angkasekwinai, P., Nallaparaju, K. C., Flaherty, S., Chang, S. H., Watarai, H., & Dong, C. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.008 · Cited by 135
“IL-25 induced IL-6, we next asked whether this effect was dependent on the IL-17RA and IL-17RB heterodimer as well as the Act1 adaptor, all of which are known to be required for IL-17RB signaling in other cells (Chang et al., 2006; Qian et al., 2007; Rickel et al., 2008; Claudio et al., 2009; Angkasekwinai et al., 201…”
BackgroundSelf-citationIL-17 Receptor Signaling Inhibits C/EBPβ by Sequential Phosphorylation of the Regulatory 2 Domain
Shen, F., Li, N., Gade, P., Kalvakolanu, D. V., Weibley, T., Doble, B. W., Woodgett, J. R., Wood, T. D., & Gaffen, S. L. (2009) · Science Signaling · doi:10.1126/scisignal.2000066 · Cited by 135
“Act1, p38, and ERK1/2 have been implicated in regulating the expression of C/EBPb and C/EBPd (13, 29), and knockdown of TRAF6 impairs the phosphorylation of C/EBPb at Thr(188) (13, 30).”
BackgroundInfluentialCytokines and effector T cell subsets causing autoimmune CNS disease
Petermann, F., & Korn, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.064 · Cited by 128
“However, in contrast to IL-17RA and IL-17RC, the functional IL-22 receptor complex is not expressed on hematopoietic cells.”
BackgroundInfluentialUp for Mischief? IL-17/Th17 in the tumour microenvironment
Maniati, E., Soper, R., & Hagemann, T. (2010) · Oncogene · doi:10.1038/onc.2010.367 · Cited by 141
“Knockdown of Act1 was subsequently shown to abrogate IL-17-induced inflammatory gene expression as well as NF-kB activation (Chang et al., 2006).”
BackgroundWong, H., & Hoeffer, C. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.010 · Cited by 129
“Once IL-17A binds and activates IL-17RA to form the complete receptor complex with IL-17RC, Act1 is recruited via the SEFIR and U-box domains (Chang et al., 2006; Liu et al., 2009).”
BackgroundHo, A. W., Shen, F., Conti, H. R., Patel, N. M., Childs, E. E., Peterson, A., Hernández‐Santos, N., Kolls, J. K., Kane, L., Ouyang, W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903739 · Cited by 136
“Act1 has been shown to co-immunoprecipitate (IP) with IL-17RA (9, 10).”
The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling
Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003699 · Cited by 128
“As a positive control, we used siRNA specific for Act1, an adaptor protein required for IL-17R signaling (18, 19).”
MethodThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity
Song, X., He, X., Li, X., & Qian, Y. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.105 · Cited by 137
Regulation and pro‐inflammatory function of interleukin‐17 family cytokines
Dong, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00709.x · Cited by 125
“Act1 physically associates with the intracellular domain of IL-17R through homotypic interactions, and knocking down Act1 expression abrogated IL-17-induced inflammatory gene expression and NF-kB activation (28).”
BackgroundSelf-citationIκBζ is a key driver in the development of psoriasis
Johansen, C., Mose, M., Ommen, P., Bertelsen, T., Vinter, H., Hailfinger, S., Lorscheid, S., Schulze-Osthoff, K., & Iversen, L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509971112 · Cited by 125
“Although IL-17 has been demonstrated to regulate IκBζ through an Act1-dependent mechanism in mice (46, 47) and humans (19), the exact signaling mechanism involved needs still to be determined.”
BackgroundIL-17 signaling in host defense and inflammatory diseases
Qian, Y., Kang, Z., Liu, C., & Li, X. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.27 · Cited by 137
“However, the key IL-1/Toll signaling molecules, MyD88 and IRAK1, are not involved in IL-17-mediated signaling and gene induction”
BackgroundWang, C., Zhang, C.-J., Martin, B. N., Bulek, K., Kang, Z., Zhao, J., Bian, G., Carman, J. A., Gao, J., Dongre, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15508 · Cited by 117
“Act1 is a key adaptor molecule in the IL-17 signalling pathway, and propagates IL-17 downstream signalling events following ligand stimulation 16,17 .”
Herjan, T., Hong, L., Bubenik, J., Bulek, K., Qian, W., Liu, C., Li, X., Chen, X., Yang, H., Ouyang, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0071-9 · Cited by 121
“Act1 (encoded by the gene TRAF3IP2, also known as CIKS) is an essential component in IL-17 signaling and also a member of the SEFIR protein family 10, 11, 12 .”
Tsai, H.-C., Velichko, S., Hung, L.-Y., & Wu, R. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/267971 · Cited by 117
“The shRNA knockdown of Act1 expression was shown to attenuate IL-17A signaling in mouse embryonic fibroblasts (MEFs) [97]; likewise, Act1-null mouse embryonic fibroblasts were shown to be unresponsive to IL-17A stimulation [98].”
BackgroundIL ‐25 in allergic inflammation
Xu, M., & Dong, C. (2017) · Immunological Reviews · doi:10.1111/imr.12558 · Cited by 121
Self-citationMuch More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
Brevi, A., Cogrossi, L. L., Grazia, G., Masciovecchio, D., Impellizzieri, D., Lacanfora, L., Grioni, M., & Bellone, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565470 · Cited by 121
“Act1 is crucial for IL-17 signaling, and it acts as adaptor and as RNA-binding protein (RBP) by forming several ribonucleoprotein particles (RNPs) (69, 76, 77).”
BackgroundInterleukin-17 as a drug target in human disease
Ivanov, S., & Lindén, A. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.004 · Cited by 123
Wang, C., Wu, L., Bulek, K., Martin, B. N., Zepp, J. A., Kang, Z., Liu, C., Herjan, T., Misra, S., Carman, J., et al. (2012) · Nature Immunology · doi:10.1038/ni.2479 · Cited by 111
“The IL-17-signaling cascade requires a key signaling molecule, Act1 (Traf3ip2/CIKS), to propagate downstream signaling events 13-15 .”
Background
Metadata
- Authors
- Chang, S. H., Park, H., & Dong, C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Dong, Chen
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 281
- Issue
- 47
- Pages
- 35603-35607
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W221516563
- Cited by
- 356
- References
- 17
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 8 · 2023: 16 · 2022: 16 · 2021: 19 · 2020: 14 · 2019: 16 · 2018: 12 · 2017: 17 · 2016: 14 · 2015: 20 · 2014: 21 · 2013: 24 · 2012: 23
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5082 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- interleukin-17 receptor, IL-17 signaling, NF-κB activation, C/EBPβ, C/EBPδ, chemokine expression, fibroblasts, inflammatory gene expression
- MeSH terms
- Animals, Humans, Inflammation, Mice, Inbred C57BL, Nuclear Proteins, Phylogeny, Protein Binding, Transcription, Genetic, Signal Transduction, CD4-Positive T-Lymphocytes, Protein Structure, Tertiary, MAP Kinase Signaling System, Adaptor Proteins, Signal Transducing, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.